| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 12/13/2022 | 40.52% | JP Morgan | $50 → $30 | Maintains | Overweight |
| 12/05/2022 | — | Morgan Stanley | Downgrades | Equal-Weight → Underweight | |
| 11/25/2022 | 12.41% | Morgan Stanley | $37 → $24 | Maintains | Equal-Weight |
| 11/22/2022 | 138.88% | BTIG | $135 → $51 | Maintains | Buy |
| 11/21/2022 | 134.19% | JP Morgan | $80 → $50 | Maintains | Overweight |
| 11/21/2022 | 40.52% | Wells Fargo | $25 → $30 | Upgrades | Underweight → Equal-Weight |
| 11/17/2022 | 110.77% | Wedbush | $50 → $45 | Maintains | Outperform |
| 11/17/2022 | 63.93% | Goldman Sachs | $40 → $35 | Maintains | Neutral |
| 11/16/2022 | 134.19% | Wedbush | $70 → $50 | Maintains | Outperform |
| 11/16/2022 | 73.3% | Morgan Stanley | $77 → $37 | Maintains | Equal-Weight |
| 11/14/2022 | 87.35% | Goldman Sachs | $64 → $40 | Maintains | Neutral |
| 11/14/2022 | 227.87% | Wedbush | $85 → $70 | Maintains | Outperform |
| 11/10/2022 | 73.3% | B of A Securities | → $37 | Downgrades | Buy → Neutral |
| 11/10/2022 | 17.1% | Wells Fargo | $50 → $25 | Maintains | Underweight |
| 10/26/2022 | 199.77% | Goldman Sachs | $108 → $64 | Downgrades | Buy → Neutral |
| 10/19/2022 | 368.38% | Craig-Hallum | $160 → $100 | Maintains | Buy |
| 10/19/2022 | 298.13% | Wedbush | $120 → $85 | Maintains | Outperform |
| 10/19/2022 | 260.66% | Morgan Stanley | $81 → $77 | Maintains | Equal-Weight |
| 10/19/2022 | 134.19% | Wells Fargo | $70 → $50 | Maintains | Underweight |
| 10/19/2022 | 602.58% | Canaccord Genuity | $200 → $150 | Maintains | Buy |
| 10/06/2022 | 227.87% | Wells Fargo | $115 → $70 | Downgrades | Overweight → Underweight |
| 10/05/2022 | 279.39% | Morgan Stanley | $77 → $81 | Maintains | Equal-Weight |
| 08/04/2022 | 532.32% | BTIG | → $135 | Initiates Coverage On | → Buy |
| 07/20/2022 | 438.64% | Wells Fargo | $100 → $115 | Maintains | Overweight |
| 07/12/2022 | 302.81% | Goldman Sachs | $100 → $86 | Maintains | Buy |
| 07/12/2022 | 260.66% | Morgan Stanley | $88 → $77 | Maintains | Equal-Weight |
| 07/01/2022 | 321.55% | JP Morgan | $200 → $90 | Maintains | Overweight |
| 06/13/2022 | 462.06% | Wells Fargo | → $120 | Initiates Coverage On | → Overweight |
| 06/09/2022 | 312.18% | Morgan Stanley | → $88 | Assumes | → Equal-Weight |
| 04/20/2022 | 743.09% | Goldman Sachs | $210 → $180 | Maintains | Buy |
| 04/20/2022 | 836.77% | Canaccord Genuity | $164 → $200 | Maintains | Buy |
| 04/08/2022 | 883.61% | Goldman Sachs | $166 → $210 | Maintains | Buy |
| 03/21/2022 | 836.77% | B of A Securities | → $200 | Initiates Coverage On | → Buy |
| 01/20/2022 | 677.52% | Goldman Sachs | $190 → $166 | Upgrades | Neutral → Buy |
| 01/19/2022 | 836.77% | JP Morgan | $300 → $200 | Maintains | Overweight |
| 12/16/2021 | 1117.8% | B. Riley Securities | → $260 | Initiates Coverage On | → Buy |
| 12/13/2021 | 789.93% | Goldman Sachs | $122 → $190 | Maintains | Neutral |
| 12/06/2021 | 1117.8% | Morgan Stanley | $181 → $260 | Maintains | Overweight |
| 11/11/2021 | 1305.15% | JP Morgan | → $300 | Initiates Coverage On | → Overweight |
| 10/27/2021 | 747.78% | Morgan Stanley | $158 → $181 | Maintains | Overweight |
| 10/20/2021 | 668.15% | Canaccord Genuity | $150 → $164 | Maintains | Buy |
| 10/20/2021 | 696.25% | Craig-Hallum | $135 → $170 | Maintains | Buy |
| 09/27/2021 | 640.05% | Morgan Stanley | → $158 | Initiates Coverage On | → Overweight |
| 06/14/2021 | 462.06% | Goldman Sachs | → $120 | Initiates Coverage On | → Neutral |
| 04/13/2021 | 672.83% | Barclays | $85 → $165 | Maintains | Equal-Weight |
| 03/30/2021 | 602.58% | Canaccord Genuity | $90 → $150 | Maintains | Buy |
| 02/04/2021 | 532.32% | Craig-Hallum | $80 → $135 | Maintains | Buy |
| 01/14/2021 | 255.97% | Barclays | → $76 | Downgrades | Overweight → Equal-Weight |
| 12/22/2020 | 274.71% | Wedbush | → $80 | Initiates Coverage On | → Outperform |
| 12/17/2020 | 152.93% | Keefe, Bruyette & Woods | → $54 | Upgrades | Market Perform → Outperform |
| 12/02/2020 | 134.19% | Craig-Hallum | → $50 | Initiates Coverage On | → Buy |
| 11/30/2020 | 87.35% | Canaccord Genuity | $26 → $40 | Maintains | Buy |
| 10/27/2020 | 21.78% | Canaccord Genuity | $19 → $26 | Maintains | Buy |
| 10/16/2020 | -15.69% | Compass Point | → $18 | Initiates Coverage On | → Buy |
| 03/16/2020 | -39.11% | Canaccord Genuity | → $13 | Initiates Coverage On | → Buy |
| 12/02/2019 | -11.01% | Barclays | → $19 | Initiates Coverage On | → Overweight |
| 11/18/2019 | -18.03% | Compass Point | → $17.5 | Initiates Coverage On | → Buy |
What is the target price for Silvergate Capital (SI)?
The latest price target for Silvergate Capital (NYSE: SI) was reported by JP Morgan on December 13, 2022. The analyst firm set a price target for $30.00 expecting SI to rise to within 12 months (a possible 40.52% upside). 36 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Silvergate Capital (SI)?
The latest analyst rating for Silvergate Capital (NYSE: SI) was provided by JP Morgan, and Silvergate Capital maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Silvergate Capital (SI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Silvergate Capital, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Silvergate Capital was filed on December 13, 2022 so you should expect the next rating to be made available sometime around December 13, 2023.
Is the Analyst Rating Silvergate Capital (SI) correct?
While ratings are subjective and will change, the latest Silvergate Capital (SI) rating was a maintained with a price target of $50.00 to $30.00. The current price Silvergate Capital (SI) is trading at is $21.35, which is out of the analyst's predicted range.
